Pharma & Healthcare
Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 07, 25
- ID: 168324
- Pages: 94
- Figures: 92
- Views: 35
The global Heparin market size was US$ 2134 million in 2024 and is forecast to a readjusted size of US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
In this report, we mainly study the Heparin API.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
The global Heparin market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
By Type: (Dominant Segment vs High-Margin Innovation)
Heparin Sodium
Heparin Calcium
By Application: (Core Demand Driver vs Emerging Opportunity)
UFH
LMWH
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Shenzhen Hepalink Pharmaceutical in Europe)
- Emerging Product Trends: Heparin Sodium adoption vs. Heparin Calcium premiumization
- Demand-Side Dynamics: UFH growth in China vs. LMWH potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Heparin market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Heparin Calcium in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., LMWH in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Heparin Sodium dominance in Europe vs. Heparin Calcium demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
In this report, we mainly study the Heparin API.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
The global Heparin market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
By Type: (Dominant Segment vs High-Margin Innovation)
Heparin Sodium
Heparin Calcium
By Application: (Core Demand Driver vs Emerging Opportunity)
UFH
LMWH
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Shenzhen Hepalink Pharmaceutical in Europe)
- Emerging Product Trends: Heparin Sodium adoption vs. Heparin Calcium premiumization
- Demand-Side Dynamics: UFH growth in China vs. LMWH potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Heparin market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Heparin Calcium in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., LMWH in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Heparin Sodium dominance in Europe vs. Heparin Calcium demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Heparin Product Scope
1.2 Heparin by Type
1.2.1 Global Heparin Sales by Type (2020 & 2024 & 2031)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Heparin by Application
1.3.1 Global Heparin Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 UFH
1.3.3 LMWH
1.4 Global Heparin Market Estimates and Forecasts (2020-2031)
1.4.1 Global Heparin Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Heparin Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Heparin Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Heparin Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Heparin Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Heparin Sales Market Share by Region (2020-2025)
2.2.2 Global Heparin Revenue Market Share by Region (2020-2025)
2.3 Global Heparin Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Heparin Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Heparin Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Heparin Market Size and Prospective (2020-2031)
2.4.2 Europe Heparin Market Size and Prospective (2020-2031)
2.4.3 China Heparin Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Heparin Historic Market Review by Type (2020-2025)
3.1.1 Global Heparin Sales by Type (2020-2025)
3.1.2 Global Heparin Revenue by Type (2020-2025)
3.1.3 Global Heparin Price by Type (2020-2025)
3.2 Global Heparin Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Heparin Sales Forecast by Type (2026-2031)
3.2.2 Global Heparin Revenue Forecast by Type (2026-2031)
3.2.3 Global Heparin Price Forecast by Type (2026-2031)
3.3 Different Types Heparin Representative Players
4 Global Market Size by Application
4.1 Global Heparin Historic Market Review by Application (2020-2025)
4.1.1 Global Heparin Sales by Application (2020-2025)
4.1.2 Global Heparin Revenue by Application (2020-2025)
4.1.3 Global Heparin Price by Application (2020-2025)
4.2 Global Heparin Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Heparin Sales Forecast by Application (2026-2031)
4.2.2 Global Heparin Revenue Forecast by Application (2026-2031)
4.2.3 Global Heparin Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Heparin Application
5 Competition Landscape by Players
5.1 Global Heparin Sales by Players (2020-2025)
5.2 Global Top Heparin Players by Revenue (2020-2025)
5.3 Global Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2024)
5.4 Global Heparin Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Heparin, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Heparin, Product Type & Application
5.7 Global Key Manufacturers of Heparin, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Heparin Sales by Company
6.1.1.1 North America Heparin Sales by Company (2020-2025)
6.1.1.2 North America Heparin Revenue by Company (2020-2025)
6.1.2 North America Heparin Sales Breakdown by Type (2020-2025)
6.1.3 North America Heparin Sales Breakdown by Application (2020-2025)
6.1.4 North America Heparin Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Heparin Sales by Company
6.2.1.1 Europe Heparin Sales by Company (2020-2025)
6.2.1.2 Europe Heparin Revenue by Company (2020-2025)
6.2.2 Europe Heparin Sales Breakdown by Type (2020-2025)
6.2.3 Europe Heparin Sales Breakdown by Application (2020-2025)
6.2.4 Europe Heparin Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Heparin Sales by Company
6.3.1.1 China Heparin Sales by Company (2020-2025)
6.3.1.2 China Heparin Revenue by Company (2020-2025)
6.3.2 China Heparin Sales Breakdown by Type (2020-2025)
6.3.3 China Heparin Sales Breakdown by Application (2020-2025)
6.3.4 China Heparin Major Customer
6.3.5 China Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Shenzhen Hepalink Pharmaceutical
7.1.1 Shenzhen Hepalink Pharmaceutical Company Information
7.1.2 Shenzhen Hepalink Pharmaceutical Business Overview
7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Shenzhen Hepalink Pharmaceutical Heparin Products Offered
7.1.5 Shenzhen Hepalink Pharmaceutical Recent Development
7.2 Yantai Dongcheng Pharmaceutical
7.2.1 Yantai Dongcheng Pharmaceutical Company Information
7.2.2 Yantai Dongcheng Pharmaceutical Business Overview
7.2.3 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Yantai Dongcheng Pharmaceutical Heparin Products Offered
7.2.5 Yantai Dongcheng Pharmaceutical Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Heparin Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Pfizer Heparin Products Offered
7.3.5 Pfizer Recent Development
7.4 Bioibérica
7.4.1 Bioibérica Company Information
7.4.2 Bioibérica Business Overview
7.4.3 Bioibérica Heparin Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Bioibérica Heparin Products Offered
7.4.5 Bioibérica Recent Development
7.5 Changzhou Qianhong Biopharma
7.5.1 Changzhou Qianhong Biopharma Company Information
7.5.2 Changzhou Qianhong Biopharma Business Overview
7.5.3 Changzhou Qianhong Biopharma Heparin Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Changzhou Qianhong Biopharma Heparin Products Offered
7.5.5 Changzhou Qianhong Biopharma Recent Development
7.6 Nanjing King-friend Biochemical Pharmaceutical
7.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
7.6.2 Nanjing King-friend Biochemical Pharmaceutical Business Overview
7.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Products Offered
7.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Development
7.7 Hebei Changshan Biochemical Pharmaceutical
7.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
7.7.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
7.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Products Offered
7.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Development
7.8 Qingdao Jiulong Biopharmaceutical
7.8.1 Qingdao Jiulong Biopharmaceutical Company Information
7.8.2 Qingdao Jiulong Biopharmaceutical Business Overview
7.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Qingdao Jiulong Biopharmaceutical Heparin Products Offered
7.8.5 Qingdao Jiulong Biopharmaceutical Recent Development
7.9 Opocrin
7.9.1 Opocrin Company Information
7.9.2 Opocrin Business Overview
7.9.3 Opocrin Heparin Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Opocrin Heparin Products Offered
7.9.5 Opocrin Recent Development
7.10 Dongying Tiandong Pharmaceutical
7.10.1 Dongying Tiandong Pharmaceutical Company Information
7.10.2 Dongying Tiandong Pharmaceutical Business Overview
7.10.3 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Dongying Tiandong Pharmaceutical Heparin Products Offered
7.10.5 Dongying Tiandong Pharmaceutical Recent Development
7.11 Aspen Oss
7.11.1 Aspen Oss Company Information
7.11.2 Aspen Oss Business Overview
7.11.3 Aspen Oss Heparin Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Aspen Oss Heparin Products Offered
7.11.5 Aspen Oss Recent Development
7.12 Yino Pharma
7.12.1 Yino Pharma Company Information
7.12.2 Yino Pharma Business Overview
7.12.3 Yino Pharma Heparin Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Yino Pharma Heparin Products Offered
7.12.5 Yino Pharma Recent Development
7.13 Nanjing Xinbai Pharmaceutical
7.13.1 Nanjing Xinbai Pharmaceutical Company Information
7.13.2 Nanjing Xinbai Pharmaceutical Business Overview
7.13.3 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Nanjing Xinbai Pharmaceutical Heparin Products Offered
7.13.5 Nanjing Xinbai Pharmaceutical Recent Development
7.14 Hubei Enoray Biopharmaceutical
7.14.1 Hubei Enoray Biopharmaceutical Company Information
7.14.2 Hubei Enoray Biopharmaceutical Business Overview
7.14.3 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Hubei Enoray Biopharmaceutical Heparin Products Offered
7.14.5 Hubei Enoray Biopharmaceutical Recent Development
7.15 Cisen Pharmaceutical
7.15.1 Cisen Pharmaceutical Company Information
7.15.2 Cisen Pharmaceutical Business Overview
7.15.3 Cisen Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Cisen Pharmaceutical Heparin Products Offered
7.15.5 Cisen Pharmaceutical Recent Development
8 Heparin Manufacturing Cost Analysis
8.1 Heparin Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Heparin
8.4 Heparin Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Heparin Distributors List
9.3 Heparin Customers
10 Heparin Market Dynamics
10.1 Heparin Industry Trends
10.2 Heparin Market Drivers
10.3 Heparin Market Challenges
10.4 Heparin Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Heparin Product Scope
1.2 Heparin by Type
1.2.1 Global Heparin Sales by Type (2020 & 2024 & 2031)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Heparin by Application
1.3.1 Global Heparin Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 UFH
1.3.3 LMWH
1.4 Global Heparin Market Estimates and Forecasts (2020-2031)
1.4.1 Global Heparin Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Heparin Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Heparin Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Heparin Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Heparin Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Heparin Sales Market Share by Region (2020-2025)
2.2.2 Global Heparin Revenue Market Share by Region (2020-2025)
2.3 Global Heparin Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Heparin Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Heparin Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Heparin Market Size and Prospective (2020-2031)
2.4.2 Europe Heparin Market Size and Prospective (2020-2031)
2.4.3 China Heparin Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Heparin Historic Market Review by Type (2020-2025)
3.1.1 Global Heparin Sales by Type (2020-2025)
3.1.2 Global Heparin Revenue by Type (2020-2025)
3.1.3 Global Heparin Price by Type (2020-2025)
3.2 Global Heparin Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Heparin Sales Forecast by Type (2026-2031)
3.2.2 Global Heparin Revenue Forecast by Type (2026-2031)
3.2.3 Global Heparin Price Forecast by Type (2026-2031)
3.3 Different Types Heparin Representative Players
4 Global Market Size by Application
4.1 Global Heparin Historic Market Review by Application (2020-2025)
4.1.1 Global Heparin Sales by Application (2020-2025)
4.1.2 Global Heparin Revenue by Application (2020-2025)
4.1.3 Global Heparin Price by Application (2020-2025)
4.2 Global Heparin Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Heparin Sales Forecast by Application (2026-2031)
4.2.2 Global Heparin Revenue Forecast by Application (2026-2031)
4.2.3 Global Heparin Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Heparin Application
5 Competition Landscape by Players
5.1 Global Heparin Sales by Players (2020-2025)
5.2 Global Top Heparin Players by Revenue (2020-2025)
5.3 Global Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2024)
5.4 Global Heparin Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Heparin, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Heparin, Product Type & Application
5.7 Global Key Manufacturers of Heparin, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Heparin Sales by Company
6.1.1.1 North America Heparin Sales by Company (2020-2025)
6.1.1.2 North America Heparin Revenue by Company (2020-2025)
6.1.2 North America Heparin Sales Breakdown by Type (2020-2025)
6.1.3 North America Heparin Sales Breakdown by Application (2020-2025)
6.1.4 North America Heparin Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Heparin Sales by Company
6.2.1.1 Europe Heparin Sales by Company (2020-2025)
6.2.1.2 Europe Heparin Revenue by Company (2020-2025)
6.2.2 Europe Heparin Sales Breakdown by Type (2020-2025)
6.2.3 Europe Heparin Sales Breakdown by Application (2020-2025)
6.2.4 Europe Heparin Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Heparin Sales by Company
6.3.1.1 China Heparin Sales by Company (2020-2025)
6.3.1.2 China Heparin Revenue by Company (2020-2025)
6.3.2 China Heparin Sales Breakdown by Type (2020-2025)
6.3.3 China Heparin Sales Breakdown by Application (2020-2025)
6.3.4 China Heparin Major Customer
6.3.5 China Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Shenzhen Hepalink Pharmaceutical
7.1.1 Shenzhen Hepalink Pharmaceutical Company Information
7.1.2 Shenzhen Hepalink Pharmaceutical Business Overview
7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Shenzhen Hepalink Pharmaceutical Heparin Products Offered
7.1.5 Shenzhen Hepalink Pharmaceutical Recent Development
7.2 Yantai Dongcheng Pharmaceutical
7.2.1 Yantai Dongcheng Pharmaceutical Company Information
7.2.2 Yantai Dongcheng Pharmaceutical Business Overview
7.2.3 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Yantai Dongcheng Pharmaceutical Heparin Products Offered
7.2.5 Yantai Dongcheng Pharmaceutical Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Heparin Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Pfizer Heparin Products Offered
7.3.5 Pfizer Recent Development
7.4 Bioibérica
7.4.1 Bioibérica Company Information
7.4.2 Bioibérica Business Overview
7.4.3 Bioibérica Heparin Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Bioibérica Heparin Products Offered
7.4.5 Bioibérica Recent Development
7.5 Changzhou Qianhong Biopharma
7.5.1 Changzhou Qianhong Biopharma Company Information
7.5.2 Changzhou Qianhong Biopharma Business Overview
7.5.3 Changzhou Qianhong Biopharma Heparin Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Changzhou Qianhong Biopharma Heparin Products Offered
7.5.5 Changzhou Qianhong Biopharma Recent Development
7.6 Nanjing King-friend Biochemical Pharmaceutical
7.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
7.6.2 Nanjing King-friend Biochemical Pharmaceutical Business Overview
7.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Products Offered
7.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Development
7.7 Hebei Changshan Biochemical Pharmaceutical
7.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
7.7.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
7.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Products Offered
7.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Development
7.8 Qingdao Jiulong Biopharmaceutical
7.8.1 Qingdao Jiulong Biopharmaceutical Company Information
7.8.2 Qingdao Jiulong Biopharmaceutical Business Overview
7.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Qingdao Jiulong Biopharmaceutical Heparin Products Offered
7.8.5 Qingdao Jiulong Biopharmaceutical Recent Development
7.9 Opocrin
7.9.1 Opocrin Company Information
7.9.2 Opocrin Business Overview
7.9.3 Opocrin Heparin Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Opocrin Heparin Products Offered
7.9.5 Opocrin Recent Development
7.10 Dongying Tiandong Pharmaceutical
7.10.1 Dongying Tiandong Pharmaceutical Company Information
7.10.2 Dongying Tiandong Pharmaceutical Business Overview
7.10.3 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Dongying Tiandong Pharmaceutical Heparin Products Offered
7.10.5 Dongying Tiandong Pharmaceutical Recent Development
7.11 Aspen Oss
7.11.1 Aspen Oss Company Information
7.11.2 Aspen Oss Business Overview
7.11.3 Aspen Oss Heparin Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Aspen Oss Heparin Products Offered
7.11.5 Aspen Oss Recent Development
7.12 Yino Pharma
7.12.1 Yino Pharma Company Information
7.12.2 Yino Pharma Business Overview
7.12.3 Yino Pharma Heparin Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Yino Pharma Heparin Products Offered
7.12.5 Yino Pharma Recent Development
7.13 Nanjing Xinbai Pharmaceutical
7.13.1 Nanjing Xinbai Pharmaceutical Company Information
7.13.2 Nanjing Xinbai Pharmaceutical Business Overview
7.13.3 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Nanjing Xinbai Pharmaceutical Heparin Products Offered
7.13.5 Nanjing Xinbai Pharmaceutical Recent Development
7.14 Hubei Enoray Biopharmaceutical
7.14.1 Hubei Enoray Biopharmaceutical Company Information
7.14.2 Hubei Enoray Biopharmaceutical Business Overview
7.14.3 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Hubei Enoray Biopharmaceutical Heparin Products Offered
7.14.5 Hubei Enoray Biopharmaceutical Recent Development
7.15 Cisen Pharmaceutical
7.15.1 Cisen Pharmaceutical Company Information
7.15.2 Cisen Pharmaceutical Business Overview
7.15.3 Cisen Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Cisen Pharmaceutical Heparin Products Offered
7.15.5 Cisen Pharmaceutical Recent Development
8 Heparin Manufacturing Cost Analysis
8.1 Heparin Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Heparin
8.4 Heparin Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Heparin Distributors List
9.3 Heparin Customers
10 Heparin Market Dynamics
10.1 Heparin Industry Trends
10.2 Heparin Market Drivers
10.3 Heparin Market Challenges
10.4 Heparin Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Heparin Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Heparin Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Heparin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Heparin Sales (B Units) by Region (2020-2025)
Table 5. Global Heparin Sales Market Share by Region (2020-2025)
Table 6. Global Heparin Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Heparin Revenue Share by Region (2020-2025)
Table 8. Global Heparin Sales (B Units) Forecast by Region (2026-2031)
Table 9. Global Heparin Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Heparin Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Heparin Revenue Share Forecast by Region (2026-2031)
Table 12. Global Heparin Sales by Type (B Units) & (2020-2025)
Table 13. Global Heparin Sales Share by Type (2020-2025)
Table 14. Global Heparin Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Heparin Price by Type (US$/B Units) & (2020-2025)
Table 16. Global Heparin Sales by Type (B Units) & (2026-2031)
Table 17. Global Heparin Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Heparin Price by Type (US$/B Units) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Heparin Sales by Application (B Units) & (2020-2025)
Table 21. Global Heparin Sales Share by Application (2020-2025)
Table 22. Global Heparin Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Heparin Price by Application (US$/B Units) & (2020-2025)
Table 24. Global Heparin Sales by Application (B Units) & (2026-2031)
Table 25. Global Heparin Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Heparin Price by Application (US$/B Units) & (2026-2031)
Table 27. New Sources of Growth in Heparin Application
Table 28. Global Heparin Sales by Company (B Units) & (2020-2025)
Table 29. Global Heparin Sales Share by Company (2020-2025)
Table 30. Global Heparin Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Heparin Revenue Share by Company (2020-2025)
Table 32. Global Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2024)
Table 33. Global Market Heparin Average Price by Company (US$/B Units) & (2020-2025)
Table 34. Global Key Manufacturers of Heparin, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Heparin, Product Type & Application
Table 36. Global Key Manufacturers of Heparin, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Heparin Sales by Company (2020-2025) & (B Units)
Table 39. North America Heparin Sales Market Share by Company (2020-2025)
Table 40. North America Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Heparin Revenue Market Share by Company (2020-2025)
Table 42. North America Heparin Sales by Type (2020-2025) & (B Units)
Table 43. North America Heparin Sales Market Share by Type (2020-2025)
Table 44. North America Heparin Sales by Application (2020-2025) & (B Units)
Table 45. North America Heparin Sales Market Share by Application (2020-2025)
Table 46. Europe Heparin Sales by Company (2020-2025) & (B Units)
Table 47. Europe Heparin Sales Market Share by Company (2020-2025)
Table 48. Europe Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Heparin Revenue Market Share by Company (2020-2025)
Table 50. Europe Heparin Sales by Type (2020-2025) & (B Units)
Table 51. Europe Heparin Sales Market Share by Type (2020-2025)
Table 52. Europe Heparin Sales by Application (2020-2025) & (B Units)
Table 53. Europe Heparin Sales Market Share by Application (2020-2025)
Table 54. China Heparin Sales by Company (2020-2025) & (B Units)
Table 55. China Heparin Sales Market Share by Company (2020-2025)
Table 56. China Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Heparin Revenue Market Share by Company (2020-2025)
Table 58. China Heparin Sales by Type (2020-2025) & (B Units)
Table 59. China Heparin Sales Market Share by Type (2020-2025)
Table 60. China Heparin Sales by Application (2020-2025) & (B Units)
Table 61. China Heparin Sales Market Share by Application (2020-2025)
Table 62. Shenzhen Hepalink Pharmaceutical Company Information
Table 63. Shenzhen Hepalink Pharmaceutical Description and Business Overview
Table 64. Shenzhen Hepalink Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 65. Shenzhen Hepalink Pharmaceutical Heparin Product
Table 66. Shenzhen Hepalink Pharmaceutical Recent Development
Table 67. Yantai Dongcheng Pharmaceutical Company Information
Table 68. Yantai Dongcheng Pharmaceutical Description and Business Overview
Table 69. Yantai Dongcheng Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 70. Yantai Dongcheng Pharmaceutical Heparin Product
Table 71. Yantai Dongcheng Pharmaceutical Recent Development
Table 72. Pfizer Company Information
Table 73. Pfizer Description and Business Overview
Table 74. Pfizer Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 75. Pfizer Heparin Product
Table 76. Pfizer Recent Development
Table 77. Bioibérica Company Information
Table 78. Bioibérica Description and Business Overview
Table 79. Bioibérica Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 80. Bioibérica Heparin Product
Table 81. Bioibérica Recent Development
Table 82. Changzhou Qianhong Biopharma Company Information
Table 83. Changzhou Qianhong Biopharma Description and Business Overview
Table 84. Changzhou Qianhong Biopharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 85. Changzhou Qianhong Biopharma Heparin Product
Table 86. Changzhou Qianhong Biopharma Recent Development
Table 87. Nanjing King-friend Biochemical Pharmaceutical Company Information
Table 88. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
Table 89. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 90. Nanjing King-friend Biochemical Pharmaceutical Heparin Product
Table 91. Nanjing King-friend Biochemical Pharmaceutical Recent Development
Table 92. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 93. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
Table 94. Hebei Changshan Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 95. Hebei Changshan Biochemical Pharmaceutical Heparin Product
Table 96. Hebei Changshan Biochemical Pharmaceutical Recent Development
Table 97. Qingdao Jiulong Biopharmaceutical Company Information
Table 98. Qingdao Jiulong Biopharmaceutical Description and Business Overview
Table 99. Qingdao Jiulong Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 100. Qingdao Jiulong Biopharmaceutical Heparin Product
Table 101. Qingdao Jiulong Biopharmaceutical Recent Development
Table 102. Opocrin Company Information
Table 103. Opocrin Description and Business Overview
Table 104. Opocrin Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 105. Opocrin Heparin Product
Table 106. Opocrin Recent Development
Table 107. Dongying Tiandong Pharmaceutical Company Information
Table 108. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 109. Dongying Tiandong Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 110. Dongying Tiandong Pharmaceutical Heparin Product
Table 111. Dongying Tiandong Pharmaceutical Recent Development
Table 112. Aspen Oss Company Information
Table 113. Aspen Oss Description and Business Overview
Table 114. Aspen Oss Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 115. Aspen Oss Heparin Product
Table 116. Aspen Oss Recent Development
Table 117. Yino Pharma Company Information
Table 118. Yino Pharma Description and Business Overview
Table 119. Yino Pharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 120. Yino Pharma Heparin Product
Table 121. Yino Pharma Recent Development
Table 122. Nanjing Xinbai Pharmaceutical Company Information
Table 123. Nanjing Xinbai Pharmaceutical Description and Business Overview
Table 124. Nanjing Xinbai Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 125. Nanjing Xinbai Pharmaceutical Heparin Product
Table 126. Nanjing Xinbai Pharmaceutical Recent Development
Table 127. Hubei Enoray Biopharmaceutical Company Information
Table 128. Hubei Enoray Biopharmaceutical Description and Business Overview
Table 129. Hubei Enoray Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 130. Hubei Enoray Biopharmaceutical Heparin Product
Table 131. Hubei Enoray Biopharmaceutical Recent Development
Table 132. Cisen Pharmaceutical Company Information
Table 133. Cisen Pharmaceutical Description and Business Overview
Table 134. Cisen Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 135. Cisen Pharmaceutical Heparin Product
Table 136. Cisen Pharmaceutical Recent Development
Table 137. Production Base and Market Concentration Rate of Raw Material
Table 138. Key Suppliers of Raw Materials
Table 139. Heparin Distributors List
Table 140. Heparin Customers List
Table 141. Heparin Market Trends
Table 142. Heparin Market Drivers
Table 143. Heparin Market Challenges
Table 144. Heparin Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Heparin Sales Market Share by Type in 2024 & 2031
Figure 4. Heparin Sodium Product Picture
Figure 5. Heparin Calcium Product Picture
Figure 6. Global Heparin Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Heparin Sales Market Share by Application in 2024 & 2031
Figure 8. UFH Examples
Figure 9. LMWH Examples
Figure 10. Global Heparin Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Heparin Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global Heparin Sales (B Units) Growth Rate (2020-2031)
Figure 13. Global Heparin Price Trends Growth Rate (2020-2031) & (US$/B Units)
Figure 14. Heparin Report Years Considered
Figure 15. Global Market Heparin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global Heparin Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America Heparin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America Heparin Sales (B Units) Growth Rate (2020-2031)
Figure 19. Europe Heparin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe Heparin Sales (B Units) Growth Rate (2020-2031)
Figure 21. China Heparin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. China Heparin Sales (B Units) Growth Rate (2020-2031)
Figure 23. Global Heparin Revenue Share by Type (2020-2025)
Figure 24. Global Heparin Sales Share by Type (2026-2031)
Figure 25. Global Heparin Revenue Share by Type (2026-2031)
Figure 26. Global Heparin Revenue Share by Application (2020-2025)
Figure 27. Global Heparin Revenue Growth Rate by Application in 2020 & 2024
Figure 28. Global Heparin Sales Share by Application (2026-2031)
Figure 29. Global Heparin Revenue Share by Application (2026-2031)
Figure 30. Global Heparin Sales Share by Company (2024)
Figure 31. Global Heparin Revenue Share by Company (2024)
Figure 32. Global 5 Largest Heparin Players Market Share by Revenue in Heparin: 2020 & 2024
Figure 33. Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 34. Manufacturing Cost Structure of Heparin
Figure 35. Manufacturing Process Analysis of Heparin
Figure 36. Heparin Industrial Chain
Figure 37. Channels of Distribution (Direct Vs Distribution)
Figure 38. Distributors Profiles
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Table 1. Global Heparin Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Heparin Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Heparin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Heparin Sales (B Units) by Region (2020-2025)
Table 5. Global Heparin Sales Market Share by Region (2020-2025)
Table 6. Global Heparin Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Heparin Revenue Share by Region (2020-2025)
Table 8. Global Heparin Sales (B Units) Forecast by Region (2026-2031)
Table 9. Global Heparin Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Heparin Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Heparin Revenue Share Forecast by Region (2026-2031)
Table 12. Global Heparin Sales by Type (B Units) & (2020-2025)
Table 13. Global Heparin Sales Share by Type (2020-2025)
Table 14. Global Heparin Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Heparin Price by Type (US$/B Units) & (2020-2025)
Table 16. Global Heparin Sales by Type (B Units) & (2026-2031)
Table 17. Global Heparin Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Heparin Price by Type (US$/B Units) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Heparin Sales by Application (B Units) & (2020-2025)
Table 21. Global Heparin Sales Share by Application (2020-2025)
Table 22. Global Heparin Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Heparin Price by Application (US$/B Units) & (2020-2025)
Table 24. Global Heparin Sales by Application (B Units) & (2026-2031)
Table 25. Global Heparin Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Heparin Price by Application (US$/B Units) & (2026-2031)
Table 27. New Sources of Growth in Heparin Application
Table 28. Global Heparin Sales by Company (B Units) & (2020-2025)
Table 29. Global Heparin Sales Share by Company (2020-2025)
Table 30. Global Heparin Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Heparin Revenue Share by Company (2020-2025)
Table 32. Global Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2024)
Table 33. Global Market Heparin Average Price by Company (US$/B Units) & (2020-2025)
Table 34. Global Key Manufacturers of Heparin, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Heparin, Product Type & Application
Table 36. Global Key Manufacturers of Heparin, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Heparin Sales by Company (2020-2025) & (B Units)
Table 39. North America Heparin Sales Market Share by Company (2020-2025)
Table 40. North America Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Heparin Revenue Market Share by Company (2020-2025)
Table 42. North America Heparin Sales by Type (2020-2025) & (B Units)
Table 43. North America Heparin Sales Market Share by Type (2020-2025)
Table 44. North America Heparin Sales by Application (2020-2025) & (B Units)
Table 45. North America Heparin Sales Market Share by Application (2020-2025)
Table 46. Europe Heparin Sales by Company (2020-2025) & (B Units)
Table 47. Europe Heparin Sales Market Share by Company (2020-2025)
Table 48. Europe Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Heparin Revenue Market Share by Company (2020-2025)
Table 50. Europe Heparin Sales by Type (2020-2025) & (B Units)
Table 51. Europe Heparin Sales Market Share by Type (2020-2025)
Table 52. Europe Heparin Sales by Application (2020-2025) & (B Units)
Table 53. Europe Heparin Sales Market Share by Application (2020-2025)
Table 54. China Heparin Sales by Company (2020-2025) & (B Units)
Table 55. China Heparin Sales Market Share by Company (2020-2025)
Table 56. China Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Heparin Revenue Market Share by Company (2020-2025)
Table 58. China Heparin Sales by Type (2020-2025) & (B Units)
Table 59. China Heparin Sales Market Share by Type (2020-2025)
Table 60. China Heparin Sales by Application (2020-2025) & (B Units)
Table 61. China Heparin Sales Market Share by Application (2020-2025)
Table 62. Shenzhen Hepalink Pharmaceutical Company Information
Table 63. Shenzhen Hepalink Pharmaceutical Description and Business Overview
Table 64. Shenzhen Hepalink Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 65. Shenzhen Hepalink Pharmaceutical Heparin Product
Table 66. Shenzhen Hepalink Pharmaceutical Recent Development
Table 67. Yantai Dongcheng Pharmaceutical Company Information
Table 68. Yantai Dongcheng Pharmaceutical Description and Business Overview
Table 69. Yantai Dongcheng Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 70. Yantai Dongcheng Pharmaceutical Heparin Product
Table 71. Yantai Dongcheng Pharmaceutical Recent Development
Table 72. Pfizer Company Information
Table 73. Pfizer Description and Business Overview
Table 74. Pfizer Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 75. Pfizer Heparin Product
Table 76. Pfizer Recent Development
Table 77. Bioibérica Company Information
Table 78. Bioibérica Description and Business Overview
Table 79. Bioibérica Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 80. Bioibérica Heparin Product
Table 81. Bioibérica Recent Development
Table 82. Changzhou Qianhong Biopharma Company Information
Table 83. Changzhou Qianhong Biopharma Description and Business Overview
Table 84. Changzhou Qianhong Biopharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 85. Changzhou Qianhong Biopharma Heparin Product
Table 86. Changzhou Qianhong Biopharma Recent Development
Table 87. Nanjing King-friend Biochemical Pharmaceutical Company Information
Table 88. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
Table 89. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 90. Nanjing King-friend Biochemical Pharmaceutical Heparin Product
Table 91. Nanjing King-friend Biochemical Pharmaceutical Recent Development
Table 92. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 93. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
Table 94. Hebei Changshan Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 95. Hebei Changshan Biochemical Pharmaceutical Heparin Product
Table 96. Hebei Changshan Biochemical Pharmaceutical Recent Development
Table 97. Qingdao Jiulong Biopharmaceutical Company Information
Table 98. Qingdao Jiulong Biopharmaceutical Description and Business Overview
Table 99. Qingdao Jiulong Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 100. Qingdao Jiulong Biopharmaceutical Heparin Product
Table 101. Qingdao Jiulong Biopharmaceutical Recent Development
Table 102. Opocrin Company Information
Table 103. Opocrin Description and Business Overview
Table 104. Opocrin Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 105. Opocrin Heparin Product
Table 106. Opocrin Recent Development
Table 107. Dongying Tiandong Pharmaceutical Company Information
Table 108. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 109. Dongying Tiandong Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 110. Dongying Tiandong Pharmaceutical Heparin Product
Table 111. Dongying Tiandong Pharmaceutical Recent Development
Table 112. Aspen Oss Company Information
Table 113. Aspen Oss Description and Business Overview
Table 114. Aspen Oss Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 115. Aspen Oss Heparin Product
Table 116. Aspen Oss Recent Development
Table 117. Yino Pharma Company Information
Table 118. Yino Pharma Description and Business Overview
Table 119. Yino Pharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 120. Yino Pharma Heparin Product
Table 121. Yino Pharma Recent Development
Table 122. Nanjing Xinbai Pharmaceutical Company Information
Table 123. Nanjing Xinbai Pharmaceutical Description and Business Overview
Table 124. Nanjing Xinbai Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 125. Nanjing Xinbai Pharmaceutical Heparin Product
Table 126. Nanjing Xinbai Pharmaceutical Recent Development
Table 127. Hubei Enoray Biopharmaceutical Company Information
Table 128. Hubei Enoray Biopharmaceutical Description and Business Overview
Table 129. Hubei Enoray Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 130. Hubei Enoray Biopharmaceutical Heparin Product
Table 131. Hubei Enoray Biopharmaceutical Recent Development
Table 132. Cisen Pharmaceutical Company Information
Table 133. Cisen Pharmaceutical Description and Business Overview
Table 134. Cisen Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 135. Cisen Pharmaceutical Heparin Product
Table 136. Cisen Pharmaceutical Recent Development
Table 137. Production Base and Market Concentration Rate of Raw Material
Table 138. Key Suppliers of Raw Materials
Table 139. Heparin Distributors List
Table 140. Heparin Customers List
Table 141. Heparin Market Trends
Table 142. Heparin Market Drivers
Table 143. Heparin Market Challenges
Table 144. Heparin Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Heparin Sales Market Share by Type in 2024 & 2031
Figure 4. Heparin Sodium Product Picture
Figure 5. Heparin Calcium Product Picture
Figure 6. Global Heparin Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Heparin Sales Market Share by Application in 2024 & 2031
Figure 8. UFH Examples
Figure 9. LMWH Examples
Figure 10. Global Heparin Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Heparin Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global Heparin Sales (B Units) Growth Rate (2020-2031)
Figure 13. Global Heparin Price Trends Growth Rate (2020-2031) & (US$/B Units)
Figure 14. Heparin Report Years Considered
Figure 15. Global Market Heparin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global Heparin Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America Heparin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America Heparin Sales (B Units) Growth Rate (2020-2031)
Figure 19. Europe Heparin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe Heparin Sales (B Units) Growth Rate (2020-2031)
Figure 21. China Heparin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. China Heparin Sales (B Units) Growth Rate (2020-2031)
Figure 23. Global Heparin Revenue Share by Type (2020-2025)
Figure 24. Global Heparin Sales Share by Type (2026-2031)
Figure 25. Global Heparin Revenue Share by Type (2026-2031)
Figure 26. Global Heparin Revenue Share by Application (2020-2025)
Figure 27. Global Heparin Revenue Growth Rate by Application in 2020 & 2024
Figure 28. Global Heparin Sales Share by Application (2026-2031)
Figure 29. Global Heparin Revenue Share by Application (2026-2031)
Figure 30. Global Heparin Sales Share by Company (2024)
Figure 31. Global Heparin Revenue Share by Company (2024)
Figure 32. Global 5 Largest Heparin Players Market Share by Revenue in Heparin: 2020 & 2024
Figure 33. Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 34. Manufacturing Cost Structure of Heparin
Figure 35. Manufacturing Process Analysis of Heparin
Figure 36. Heparin Industrial Chain
Figure 37. Channels of Distribution (Direct Vs Distribution)
Figure 38. Distributors Profiles
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232